Alzamend Neuro Inc (ALZN) SEC filings
Every SEC filing by Alzamend Neuro Inc (CIK 0001677077) in the last two years, with each form explained in plain English and links to the SEC's copies. Industry: Pharmaceutical Preparations. ALZN stock report · earnings · news
Annual & quarterly reports
- 2026-09-10 · 10-Q Quarterly report · document
- 2026-07-22 · 10-K Annual report · document
- 2026-03-11 · 10-Q Quarterly report · document
- 2025-12-09 · 10-Q Quarterly report · document
- 2025-09-10 · 10-Q Quarterly report · document
- 2025-07-22 · 10-K Annual report · document
- 2025-03-10 · 10-Q Quarterly report · document
- 2024-12-11 · 10-Q Quarterly report · document
Major events
- 2026-11-18 · 8-K Regulation FD disclosure · document
- 2026-11-17 · 8-K Other event · document
- 2026-11-10 · 8-K/A New material agreement · Unregistered share sale · Bylaw or charter change · document
- 2026-09-29 · 8-K Regulation FD disclosure · document
- 2026-08-03 · 8-K New material agreement · Delisting notice or listing rule issue · Unregistered share sale · Bylaw or charter change · document
- 2026-07-21 · 8-K Other event · document
- 2026-04-17 · 8-K Shareholder vote results · document
- 2026-03-20 · 8-K Delisting notice or listing rule issue · document
- 2026-03-06 · 8-K New material agreement · document
- 2025-11-18 · 8-K Other event · document
- 2025-10-14 · 8-K Bylaw or charter change · document
- 2025-10-09 · 8-K Unregistered share sale · document
- 2025-09-25 · 8-K Unregistered share sale · document
- 2025-08-01 · 8-K Unregistered share sale · document
- 2025-07-23 · 8-K Earnings results · document
- 2025-07-09 · 8-K Bylaw or charter change · document
- 2025-05-08 · 8-K Bylaw or charter change · Regulation FD disclosure · document
- 2025-04-25 · 8-K Shareholder vote results · document
- 2025-03-03 · 8-K Bylaw or charter change · document
- 2025-02-28 · 8-K New material agreement · Unregistered share sale · document
- 2024-12-12 · 8-K Earnings results · document
Big shareholders
- 2025-10-07 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
- 2025-10-03 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
- 2025-09-30 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
- 2025-09-25 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
- 2025-09-23 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
- 2025-08-01 · SCHEDULE 13D/A Over 5% stake, active investor (amended) · document
Proxy & votes
- 2026-08-28 · PRE 14A Preliminary proxy statement · document
- 2026-02-26 · DEFA14A Additional proxy material · document
- 2026-02-26 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
- 2026-02-09 · PRE 14A Preliminary proxy statement · document
- 2025-03-19 · DEFA14A Additional proxy material · document
- 2025-03-17 · DEFA14A Additional proxy material · document
- 2025-03-13 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
- 2025-02-28 · PRE 14A Preliminary proxy statement · document
Offerings & registrations
- 2026-11-17 · S-3 Shelf registration · document
- 2026-08-21 · S-1 Registration (IPO or new shares) · document
- 2026-03-06 · 424B5 Prospectus supplement · document
- 2025-04-09 · 424B3 Prospectus · document
- 2025-04-08 · EFFECT Registration takes effect · document
- 2025-03-27 · S-1/A Registration (IPO or new shares) (amended) · document
- 2025-03-13 · S-3 Shelf registration · document
39 insider filings (Forms 3, 4, 5 and 144) in the same period.
Filings link to sec.gov. Research data, not investment advice. Latest SEC filings